Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Widger, John ^a   Oliver, Mark R ^a,b,c   O'Connell, Michele ^a,c   Cameron, Fergus J ^a,b,c   Ranganathan, Sarath ^a,b,c   Robinson, Phil J ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LUNG DISEASE; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ARTIFACTS; CHILD; CYSTIC FIBROSIS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LUNG; MALE; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 84866397781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044844     Document Type: Article

References (17)

1. Soulsby N, Bell S, Greville H, Doecke C, (2009) Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new? Intern Med J 39: 527-31.
2. Battezzati A, Mari A, Zazzeron L, Alicandro G, Claut L, et al. (2011) Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients. Eur J Endocrinol 165: 69-76.
3. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, et al. (2009) Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 32: 1626-31.
4. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, et al. (2010) Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 33: 2697-708.
5. Downey DG, Brockbank S, Martin SL, Ennis M, Elborn JS, (2007) The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol 42: 729-35.
6. Preissig CM, Rigby MR Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory, cardiovascular failure: a prospective observational study, (2009) Crit Care. 13: R27.
7. Sc NN, Shoseyov D, Kerem E, Zangen DH, (2010) Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation. J Cyst Fibros. May 9(3): 199-204.
8. WHO Expert Committee on Diabetes Mellitus: second report (1980) World Health Organ Tech Rep Ser. 646: 1-80.
9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 26: 319-38.
10. Le Floch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L, (1990) Blood glucose area under the curve. Methodological aspects. Diabetes Care 13: 172-5.
11. Sanders DB, Hoffman LR, Emerson J, Gibson RL, Rosenfeld M, et al. (2010) Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 45: 127-34.
12. Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, et al. (2010) Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 33: 2677-83.
13. Olansky L, Kennedy L, (2010) Finger-stick glucose monitoring: issues of accuracy and specificity. Diabetes Care 33: 948-9.
14. Bell SC, Bowerman AM, Nixon LE, Macdonald IA, Elborn JS, et al. (2000) Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest 30: 553-9.
15. Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, et al. (2009) Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 180: 802-8.
16. Goss CH, Burns JL, (2007) Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 62: 360-7.
17. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, et al. (2010) Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 33: 2697-708.